Prostatype Genomics AB: management transactions · Finland · FIN-FSA

Browse the full insider trade history of Prostatype Genomics AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Prostatype Genomics AB has published 4 insider filings. Market capitalisation: €41.3m. The latest transaction was disclosed on 7 October 2025 (Purchase). Among the most active insiders: Anders Lundberg. The full history is free.